ASH 2018: Expert overview of the latest in CLL, ALL and AML
ASH 2018: Expert overview of the latest in CLL, ALL and AML
Updates on the ELIANA trial for acute lymphocytic leukaemia in young patients
Determining the prognosis of patients with myelodysplastic syndromes using machine learning
The benefits of a stem cell transplant after CAR T-cell therapy in paediatric patients
Long term data from JULIET trial, using tisagenlecleucel for patients with relapsed or treatment-resistant DLBCL
Link between gut microbiota and haematopoietic cell transplantation outcomes
Machine learning algorithm improves prognosis accuracy for patients with myelodysplastic syndromes
New therapies for transfusion dependent MDS patients
Results from the MEDALIST trial for patients with anaemia in MDS
Luspatercept reduces need for blood transfusions in beta thalassemia and MDS
Cancer care in areas of drug conflict
Cancer control in areas of conflict